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Background:  Measurement of unbound free fatty acid (FFAu) may be valuable for diagnosis or exclusion of acute coronary syndrome (ACS). We 
sought to determine the value of serial FFAu measurement relative to highly sensitive troponin I (hsTnI) for ACS evaluation.
Methods:  Patients presenting to the emergency department with symptoms suggestive of ACS had hsTnI (Singulex, Inc) and FFAu levels (FFA 
Sciences) measured at baseline and 2-4 hrs after presentation. hsTnI was considered elevated if above the 99th percentile value (6.28 pg/mL), 
while FFAu results were generated from a composite of 7 different probes. Area under the curve (AUC), net reclassification index (NRI) and integrated 
discrimination improvement (IDI) analyses were applied. ACS was judged using standard criteria.
Results:  180 patients were studied; 34 (19%) had a final diagnosis of ACS. At baseline hsTnI had sensitivity of 59%, specificity of 90%, positive 
predictive value (PPV) of 59% and negative predictive value (NPV) of 90%. At 2-4 hours, hsTnI had 59% sensitivity, 87% specificity, 51% PPV and 
90% NPV. Baseline FFAu had 71% sensitivity, 73% specificity, 38% PPV and 91% NPV; at 2-4 hours FFAu had 53% sensitivity, 71% specificity, 35% 
PPV and 88% NPV. AUC, IDI and NRI analyses are detail in the table. An hsTnI at 2-4 hours added minimally to baseline, while FFAu added diagnostic 
information to hsTnI at baseline and 2-4 hours.
Conclusions:  Measurement of FFAu at presentation and at 2-4 hours adds to the diagnostic accuracy of hsTnI for detection of ACS. 
Comparison AUC marker 1
AUC marker 1+ 
marker 2
Change in 
AUC 
P value, AUC 
change
Relative IDI
P value, 
IDI
Relative NRI P value, NRI
Baseline hsTnI plus 2-4 
hour hsTnI
0.746 0.753 0.007 .04 .71% .26 3.4% .03
Baseline FFAu plus 2-4 
hour FFAu
0.716 0.760 0.04 .06 11% .35 79% <.0001
Baseline hsTnI plus 
baseline FFAu
0.746 0.839 0.09 .001 31% .006 49% .002
2-4 hour hsTnI plus 2-4 
hour FFAu
0.729 0.800 .071 .01 21% .06 35% .03
